Literature DB >> 16771643

Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel.

Masaya Yamamoto1, Yoshitake Takahashi, Yasuhiko Tabata.   

Abstract

The objective of this study is to investigate the feasibility of a biodegradable hydrogel of gelatin as the controlled release carrier of bone morphogenetic protein-2 (BMP-2) suitable for enhancement of bone regeneration at a segmental bone defect. Hydrogels with three different water contents were prepared through glutaraldehyde crosslinking of gelatin with an isoelectric point of 9.0 under varied reaction conditions. Segmental critical-sized defects (20 mm) were created at the ulnar bone of skeletally mature New Zealand white rabbits, and gelatin hydrogels incorporating BMP-2 (17 microg/hydrogel) were implanted into the defects. When bone regeneration was evaluated by soft x-ray observation and bone mineral density (BMD) measurement, the gelatin hydrogels incorporating BMP- 2 exhibited significantly high osteoinduction activity compared with that of free BMP-2, although the activity depended on the water content of the hydrogels. Significantly higher BMD enhancement was observed in the gelatin hydrogel with a water content of 97.8 wt% than that with the lower or higher water content. We concluded that the biodegradable gelatin hydrogel is a promising controlled release carrier of BMP-2 for bone regeneration at the segmental bone defect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771643     DOI: 10.1089/ten.2006.12.1305

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  23 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells.

Authors:  Lisa Haines-Butterick; Karthikan Rajagopal; Monica Branco; Daphne Salick; Ronak Rughani; Matthew Pilarz; Matthew S Lamm; Darrin J Pochan; Joel P Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

3.  Biomechanical evaluation of regenerating long bone by nanoindentation.

Authors:  Takuya Ishimoto; Takayoshi Nakano; Masaya Yamamoto; Yasuhiko Tabata
Journal:  J Mater Sci Mater Med       Date:  2011-03-01       Impact factor: 3.896

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

5.  Dual growth factor delivery from bilayered, biodegradable hydrogel composites for spatially-guided osteochondral tissue repair.

Authors:  Steven Lu; Johnny Lam; Jordan E Trachtenberg; Esther J Lee; Hajar Seyednejad; Jeroen J J P van den Beucken; Yasuhiko Tabata; Mark E Wong; John A Jansen; Antonios G Mikos; F Kurtis Kasper
Journal:  Biomaterials       Date:  2014-07-18       Impact factor: 12.479

Review 6.  Clinical translation of controlled protein delivery systems for tissue engineering.

Authors:  Kara L Spiller; Gordana Vunjak-Novakovic
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

7.  An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects.

Authors:  Yash M Kolambkar; Kenneth M Dupont; Joel D Boerckel; Nathaniel Huebsch; David J Mooney; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Biomaterials       Date:  2010-09-22       Impact factor: 12.479

8.  Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects.

Authors:  Yash M Kolambkar; Joel D Boerckel; Kenneth M Dupont; Mehmet Bajin; Nathaniel Huebsch; David J Mooney; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Bone       Date:  2011-05-18       Impact factor: 4.398

Review 9.  Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances.

Authors:  Fei Wu; Tuo Jin
Journal:  AAPS PharmSciTech       Date:  2008-12-16       Impact factor: 3.246

10.  Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals.

Authors:  Philipp Leucht; Jie Jiang; Du Cheng; Bo Liu; Girija Dhamdhere; Mark Yang Fang; Stefanie D Monica; Jonathan J Urena; Whitney Cole; Lane R Smith; Alesha B Castillo; Michael T Longaker; Jill A Helms
Journal:  J Bone Joint Surg Am       Date:  2013-07-17       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.